send to a friend by email

JPH posts net income of $1.03 million in 9M 2014

2014-10-30

According to Jerusalem Pharmaceuticals Company JPH’s consolidated data for the first nine months of the year, net profit after taxes reached 1,033,909 USD, compared with a net profit after taxes of 1,609,305 USD from the first nine months of 2013, a net decrease of 35.8%. Total assets of the company reached 51,037,149 USD as of September 30^th, 2014, compared to total assets of 53,934,080 USD as of December 31^st, 2013, a net decrease of 5.4%. Total liabilities of the company reached 14,687,229 USD as of September 30^th, 2014, compared to total liabilities of 16,250,816 USD as of December 31^st, 2013, a net decrease of 9.6%. Net ownership equity of the company reached 36,349,920 USD (including 508,054 USD Non-controlling interest) as of September 30^th, 2014, compared with a net ownership equity of 37,683,265 USD (including 705,854 USD Non-controlling interest) as of December 31^st, 2013, a net decrease of 3.5% in the first nine months.